The flexibility of AMT was further illustrated by its ability to target uridine-dependent pancreatic ductal adenocarcinoma by upregulating uridine phosphorylase 1 (UPP1) in adipose organoids—outcompeting the cancer for its essential metabolic substrate and impeding tumor growth [115]. The gene discussed is UPP1; the disease is pancreatic ductal adenocarcinoma.